Tilray Brands, Inc. (TLRY) closed at $0.78, down by -3.76%, underperforming the S&P 500, which saw a 0.53% loss. The stock has fallen by 39.33% in the past month, while the Medical sector gained 7.75% and the S&P 500 lost 0.5%.

Analysts expect Tilray’s EPS to be -$0.02 in the upcoming earnings report, a 80% increase from last year. Revenue is forecasted at $209.65 million, down 0.62% year-over-year. Full-year estimates project earnings of -$0.05 per share and revenue of $867.01 million, showing changes of -600% and +5.56%, respectively.

Tilray Brands, Inc. falls under the Medical – Products industry, ranking 161 out of 250+. The Zacks Industry Rank indicates it is in the bottom 35% of industries. Top-rated industries outperform lower-rated ones by 2 to 1. Keep an eye on Zacks.com for stock-moving metrics.

An emerging semiconductor company, not as known as NVIDIA, is poised for growth in AI, ML, and IoT. With global semiconductor manufacturing set to nearly double by 2028, this company stands to benefit. Learn about this stock for free and explore more investment research from Zacks.

For more information on Tilray Brands, Inc. and other investment opportunities, visit Zacks Investment Research.

Read more at Nasdaq: Tilray Brands, Inc. (TLRY) Registers a Bigger Fall Than the Market: Important Facts to Note